Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA590029
Max Phase: Preclinical
Molecular Formula: C24H22ClN3O4
Molecular Weight: 451.91
Molecule Type: Small molecule
Associated Items:
ID: ALA590029
Max Phase: Preclinical
Molecular Formula: C24H22ClN3O4
Molecular Weight: 451.91
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1ccc(C(=O)N[C@@H](Cc2ccc(O)cc2)C(=O)N/N=C/c2ccc(Cl)cc2)cc1
Standard InChI: InChI=1S/C24H22ClN3O4/c1-32-21-12-6-18(7-13-21)23(30)27-22(14-16-4-10-20(29)11-5-16)24(31)28-26-15-17-2-8-19(25)9-3-17/h2-13,15,22,29H,14H2,1H3,(H,27,30)(H,28,31)/b26-15+/t22-/m0/s1
Standard InChI Key: BAIAJKCTBNBHFB-WGLQLPMYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 451.91 | Molecular Weight (Monoisotopic): 451.1299 | AlogP: 3.55 | #Rotatable Bonds: 8 |
Polar Surface Area: 100.02 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 9.50 | CX Basic pKa: 1.27 | CX LogP: 4.23 | CX LogD: 4.22 |
Aromatic Rings: 3 | Heavy Atoms: 32 | QED Weighted: 0.36 | Np Likeness Score: -0.90 |
1. Jin Y, Tan Z, He M, Tian B, Tang S, Hewlett I, Yang M.. (2010) SAR and molecular mechanism study of novel acylhydrazone compounds targeting HIV-1 CA., 18 (6): [PMID:20188575] [10.1016/j.bmc.2010.02.003] |
Source(1):